LAUSR

OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis.

Sign Up to like & get
recommendations!
1 Published in 2021 at "Translational oncology"

DOI: 10.1016/j.tranon.2021.101331

Abstract: BACKGROUND Gallbladder cancer (GBC) is a highly lethal malignancy that carries an extremely poor prognosis due to its chemoresistant nature. Cisplatin (CDDP) is a first-line chemotherapeutic for GBC; however, patients experienced no benefit when treated… read more here.

Keywords: gbc; olfm4 depletion; expression; gallbladder cancer ... See more keywords